HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hollenhorst, J. Articles by Piepenbrock, S. Search for Related Content PubMed PubMed Citation Articles by Hollenhorst, J. Articles by Piepenbrock, S. Social Bookmarking                      What's this?

Using Intranasal Midazolam Spray to Prevent Claustrophobia Induced by MR Imaging

¹ Department of Anaesthesiology, Medical School of Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
² Present address: University Department of Anaesthesiology, The University of Liverpool, Duncan Building, Daulby St., Liverpool L69 36A, United Kingdom.
³ Department of Neuroradiology, Medical School of Hannover, 30625 Hannover, Germany.

OBJECTIVE. Up to 37% of patients undergoing MR imaging examinations experience moderate to severe levels of anxiety that necessitate the termination of the procedure in 5-10% of patients. Although the clinical use of MR imaging has increased, effective procedures to handle claustrophobia are lacking. We evaluated the effectiveness of intranasally administered midazolam spray in preventing claustrophobic responses of patients undergoing MR imaging.

SUBJECTS AND METHODS. Fifty-four patients scheduled for MR imaging were included in this prospective study. Anxiety and sedation of patients were evaluated before drug administration, immediately before MR imaging, and at the end of the procedure. The Spielberger State-Trait Anxiety Inventory, the visual analogue scale of anxiety, and a five-point sedation scale were used. Half the patients received intranasal spray applications of 4 mg midazolam, whereas the other patients received a placebo, in a randomized, double-blind study design (six sprayings of 0.5% midazolam solution or NaCl 0.9%, respectively). The intensity of the sensation of burning of the nasal mucosa was rated by patients using a three-point scale (no, slight, or strong burning). The quality of scan images was evaluated by a radiologist using a five-point scale (0 = extremely poor, 5 = excellent).

RESULTS. No cancellations occurred with patients who received midazolam, whereas four of 27 patients receiving placebo panicked and terminated the scanning procedure. The initial anxiety and sedation scores did not differ between the groups. Patients who received midazolam spray were more sedated and less anxious immediately before entering the MR scanner and reported a more intense slight transient burning of the nasal mucosa than those in the placebo group. The quality of the MR image was higher in the midazolam group.

CONCLUSION. A sizeable reduction in MR imaging—related anxiety and improved MR image quality were seen with patients who received intranasal midazolam spray. With the exception of transient burning of the nasal mucosa, no adverse effects were reported. This simple and safe method is useful in sedating patients for MR imaging and other minor procedures.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Karst, M. Winterhalter, S. Munte, B. Francki, A. Hondronikos, A. Eckardt, L. Hoy, H. Buhck, M. Bernateck, and M. Fink Auricular Acupuncture for Dental Anxiety: A Randomized Controlled Trial Anesth. Analg., February 1, 2007; 104(2): 295 - 300. [Abstract] [Full Text] [PDF]